Femoral arter embolisinin ilk semptom olduğu sol atrial miksoma: Olgu sunumu

Kardiak miksomalar en sık görülen primer kalp tümörleridir ve sol atrial yerleşimli olduklarında sıklıkla sistemik emboliye neden olurlar. Sol bacakta emboliye bağlı akut iskemik değişikliklerle başvuran kardiak miksomalı genç bir olgu sunuldu. Embolinin histolojik incelemesinde, trombüs alanları yanısıra, miksoid zeminde iğsi, yer yer yıldızsı, hiperkromatik hücrelerin görülmesi nedeniyle kardiak miksomanın sistemik embolizasyonu olabileceği düşünüldü. Transtorasik iki boyutlu ekokardiyografide primer kardiak tümör tespit edildi. Cerrahi eksizyon materyalinde miksoma tanısı kanıtlandı. Ayrıca, immunhistokimyasal olarak, kardiak miksoma ile miksoid trombüs ayırıcı tanısının yapılmasında kalretinin antikoru kullanıldı. Embolizasyona zemin hazırlayacak aritmi ve aterosklerozu bulunmayan genç hastalarda periferik embolilerin nedeni olarak sol atrial miksomalardan şüphelenilmelidir. Ayrıca kardiak miksoma ve miksoid trombüs ayırıcı tanısında immunhistokimyasal olarak kalretinin antikoru önemli bir role sahiptir.

Femoral arterial embolus as first presentation of left atrial myxoma: Case report

Cardiac myxomas are the most common primary tumor of the heart and they cause systemic embolization if they are located in the left atrium. We report a young case of cardiac myxoma presenting as acute ischemia of limb due to embolic phenomena. In histological study, besides the thrombus, there were stellate and fusiform cells with hiperchromatic nuclei in a myxoid matrix. It was thought that it could be systemic embolization of a cardiac myxoma.Transthoracic two dimensinal cardiac echocardiography showed the primary cardiac tumor. The cardiac myxoma diagnosis was also confirmed in surgical specimen. Calretinin antibody was used in the differential diagnosis of cardiac myxoma and a myxoid thrombus. Left atrial myxoma should be suspected as a cause of systemic embolization in young patients without arrhythmia and atherosclerosis. Calretinin antibody is a useful marker in differential diagnosis of cardiac myxoma and myxoid thrombus.

___

  • 1. Burke AP, Virmani R. Cardiac myxoma. A clinicopathologic study. Am J Clin Pathol 1993; 100:671-80.
  • 2. Burke AP, Virmani R. Tumors of the Heart and Great Vessels. Washington, DC: Armed Forces Institute of Pathology; 1996. Atlas of Tumor Pathology, third series, Fascicle 16.
  • 3. Silver MD, Gotlieb Al, Schoen FJ. Cardiovascular Pathology. 3rd edition. 2001; 591-5.
  • 4. BortolottiV, Maraglino G, Rubino M, et al. Surgical excision of intracardiac myxomas: a 20 year follow-up. Ann Thorac Surg 1990; 49: 449-53.
  • 5. Stafhan B, Torbjörn I. Cardiac myxoma: 40 years expierence in 63 patients. Ann Thorac Surg 1997; 63: 697-700.
  • 6. Alvarez-Sabin J, Lozano M, Sastre-Garriga J et al.Transient ischemic attack: a common initial manifestation of cardiac myxomas. Eur Neurol 2001; 45: 165-70.
  • 7. Errichetti A, Weyman AE. Cardiac tumors and masses. In: Weyman AE,ed. Princples and practise of ecocardiography.2nd ed. .Philadelphia: Lea& Febriger 1994: 1135-77.
  • 8. Tomvall Gt Olin C. Massive embolization of cardiac myxoma. Â case report. Acta Med Scand 1979;206:123-6.
  • 9. Matsuoka S, Ito M, Shinonome T, et al. An autopsy case of cerebral embolism caused by atrial myxoma. No Sshinkei Geka 1992; 20: 255-9.
  • 10. Val-Bernal JF, Acebo E, Gomez-Roman JJ, Garijo MF. Anticipated diagnosis of left atrial myxoma following histological investigation of limb embolectomy specimens: A report of two cases. Pathology Int 2003; 53: 489-94.
  • 11. Posacıoğlu H, Çıkırıkçıoğlu M, Yavuzgil O, Memiş A. Eyer tarzında aortik emboli ve birden fazla periferik arteriyel embolinin ilk semptom olduğu sol atrial miksoma olgusu. Tanısal ve girişimsel radyoloji 1999; 5: 218-20.
  • 12. Carney JA. Differences between nonfamiiial and familial cardiac myxoma. Am J Surg Pathol 1985; 9: 53-55.
  • 13. Deshpande A, Venugopal P, Kumar AS, et al. Phenotypic characterization of cellular components of cardiac myxoma: a light microscopy and immunohistochemistry study. Hum Pathol 1996; 27:1056-9.
  • 14. Farrell DJ, Bulmer E, Angus B, et al. Immunohistochemical expression of endothelial markers in left atrial myxomas: a study of six cases. Histopathology 1996; 28:147-152.
  • 15. Landon G, Ordonez NG, Guarda LA. Cardiac myxomas: an immunohistochemical study using endothelial, histiositic and smooth- muscle cell markers. Arch Pathol Lab Med 1986; 110: 116-120.
  • 16. Terracciano LM, Mhawech P, Suess K, et al. Calretinin as a marker for cardiac myxoma. Am J Clin Pathol 2000; 114: 754-59.
  • 17. Acebo E, Val-Bernal JF, Gomez-Roman JJ. Thrombomodulin, calretinin and c-kitt (CD117) expression in cardiak myxoma. Histol Histopathol 2001; 16: 1031-8.
  • 18. Krikler DM, Rode J, Davies MJ, etal. Atrial myxoma: a tumor in search of its origins. Br Heart J 1992; 67: 89-91.
Ege Tıp Dergisi-Cover
  • ISSN: 1016-9113
  • Yayın Aralığı: Yılda 4 Sayı
  • Başlangıç: 1962
  • Yayıncı: Ersin HACIOĞLU